Camp4 Therapeutics CAMP
NASDAQ CAMP
$4.41 -0.08 (-1.79%)
As of: Sep 4, 2026 · 3:59 PM EDT

Camp4 Therapeutics (CAMP) Other Operating Expenses (2025)

Camp4 Therapeutics (CAMP) posted Other Operating Expenses of $55.3 million for Q4 2025, up 11086.03% sequentially from $494000.0 in Q3 2025.

Analysis

Camp4 Therapeutics (CAMP) Other Operating Expenses (2025) Analysis & Trends

Camp4 Therapeutics has reported Other Operating Expenses for 1 years, with the latest figure at $55.3 million in Q4 2025.

  • Quarterly Other Operating Expenses changed N/A year-over-year to $55.3 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $55.8 million (changed N/A YoY) and the FY2025 annual result came in at $55.8 million, changed N/A from the prior year.
  • Other Operating Expenses climbed to $55.3 million in Q4 2025 per CAMP's latest filing, from $494000.0 in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $55.3 million in Q4 2025 and troughed at $494000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Camp4 Therapeutics 260.10 Mn 260.10 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 494,000.00